Nath Bio-Genes (India) Limited (NSE: NATHBIOGEN)
India
· Delayed Price · Currency is INR 184.88
-3.63 (-1.93%)
Dec 24, 2024, 3:29 PM IST
Nath Bio-Genes (India) Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
| Net Income | 389.81 | 396.19 | 350.11 | -673.85 | 556.62 | 504.84 | Upgrade
|
| Depreciation & Amortization | 33.82 | 32.52 | 30.12 | 30.84 | 28.16 | 14.53 | Upgrade
|
| Other Amortization | 0.09 | 0.09 | - | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.03 | -0.01 | 0.01 | -0.04 | -0.04 | -0.27 | Upgrade
|
| Provision & Write-off of Bad Debts | 2.4 | 2.4 | 1.17 | 4.5 | -3.37 | -3.28 | Upgrade
|
| Other Operating Activities | 90.92 | 83.8 | 100.38 | 998.3 | 81.04 | 23.98 | Upgrade
|
| Change in Accounts Receivable | 710.92 | 27.65 | -118.83 | 210.23 | -20.58 | 13.55 | Upgrade
|
| Change in Inventory | -44.21 | -224.63 | 124.96 | 59.57 | -219.92 | -489.52 | Upgrade
|
| Change in Accounts Payable | 93.87 | 155.61 | -150.46 | 199.92 | -229.73 | 180.04 | Upgrade
|
| Change in Other Net Operating Assets | -1,165 | 272.32 | 46.2 | -658.99 | -181.05 | -149.09 | Upgrade
|
| Operating Cash Flow | 112.45 | 745.94 | 383.67 | 170.48 | 11.13 | 94.79 | Upgrade
|
| Operating Cash Flow Growth | -23.50% | 94.42% | 125.05% | 1431.83% | -88.26% | - | Upgrade
|
| Capital Expenditures | -295.08 | -267.76 | -28.81 | -210.04 | -115.47 | -42.38 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.5 | 0.5 | 0.47 | 0.73 | 1.53 | 4.65 | Upgrade
|
| Sale (Purchase) of Intangibles | - | - | -0.68 | -0.13 | -0.52 | -119.66 | Upgrade
|
| Investment in Securities | -9.97 | -9.98 | -0 | -0 | -0.5 | -0 | Upgrade
|
| Other Investing Activities | 38.6 | 3.22 | 0.18 | 10.93 | 12.14 | 13.02 | Upgrade
|
| Investing Cash Flow | -265.96 | -274.01 | -28.84 | -198.51 | -102.82 | -144.37 | Upgrade
|
| Short-Term Debt Issued | - | 59.18 | 133.67 | 24.31 | 248.67 | 123.14 | Upgrade
|
| Long-Term Debt Issued | - | 24.24 | - | 0.12 | 3.53 | - | Upgrade
|
| Total Debt Issued | 201.73 | 83.42 | 133.67 | 24.43 | 252.2 | 123.14 | Upgrade
|
| Short-Term Debt Repaid | - | -32.08 | -8.51 | -102.63 | - | - | Upgrade
|
| Long-Term Debt Repaid | - | - | -2.62 | - | - | -2.05 | Upgrade
|
| Total Debt Repaid | -54.48 | -32.08 | -11.13 | -102.63 | - | -2.05 | Upgrade
|
| Net Debt Issued (Repaid) | 147.25 | 51.34 | 122.54 | -78.2 | 252.2 | 121.09 | Upgrade
|
| Common Dividends Paid | -38.81 | -38.01 | -38.01 | -38.01 | - | - | Upgrade
|
| Other Financing Activities | -90.68 | -91.11 | -101.21 | -106.11 | -88.19 | -65.46 | Upgrade
|
| Financing Cash Flow | 17.76 | -77.78 | -16.68 | -222.32 | 164.01 | 55.63 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | 0 | 0 | - | - | -0 | - | Upgrade
|
| Net Cash Flow | -135.75 | 394.15 | 338.15 | -250.36 | 72.31 | 6.05 | Upgrade
|
| Free Cash Flow | -182.63 | 478.18 | 354.85 | -39.56 | -104.34 | 52.42 | Upgrade
|
| Free Cash Flow Growth | - | 34.75% | - | - | - | - | Upgrade
|
| Free Cash Flow Margin | -5.20% | 14.37% | 11.77% | -1.42% | -3.39% | 1.87% | Upgrade
|
| Free Cash Flow Per Share | -9.58 | 25.16 | 18.67 | -2.08 | -5.49 | 2.76 | Upgrade
|
| Cash Interest Paid | 91.29 | 91.11 | 101.21 | 106.11 | 88.19 | 65.46 | Upgrade
|
| Cash Income Tax Paid | 0.45 | 3.4 | 9.22 | 28.77 | 3.04 | 15.2 | Upgrade
|
| Levered Free Cash Flow | -262.71 | 332.32 | 141.3 | 697.65 | -569.41 | -285.84 | Upgrade
|
| Unlevered Free Cash Flow | -208.67 | 386.25 | 201.14 | 760.93 | -520.02 | -246.24 | Upgrade
|
| Change in Net Working Capital | 236.11 | -329.23 | 86.24 | -724.2 | 834.29 | 432.26 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.